Author

Pratyush Pragyandipta

Observed names: P. Pragyandipta, Pragyandipta, Pratyush

Observed institution: Sambalpur University

ORCID: 0000-0001-9378-4737

Observed ORCID: 0000-0001-9378-4737

OpenAlex ID: A5081775390

Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents

2021 · Amiya Kumar Patel, Rajesh Kumar Meher, et al. · Journal of Molecular Graphics and Modelling · 19

Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer

2021 · Rajesh Kumar Meher, Pratyush Pragyandipta, et al. · Journal of Biomolecular Structure and Dynamics · 16

Rational design of novel N‐alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents

2021 · Rajesh Kumar Meher, Pratyush Pragyandipta, et al. · Chemical Biology & Drug Design · 13

Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model

2023 · Pratyush Pragyandipta, Ravi Kumar Pedapati, et al. · Chemico-Biological Interactions · 12

Deciphering the antibiofilm potential of 2-Phenylethyl methyl ether (PEME), a bioactive compound of Kewda essential oil against Staphylococcus aureus

2023 · Priya Cheruvanachari, Subhaswaraj Pattnaik, et al. · Microbial Pathogenesis · 10

Development of 9-(N-arylmethylamino) congeners of noscapine: the microtubule targeting drugs for the management of breast cancer

2023 · Pratyush Pragyandipta, Manas Ranjan Naik, et al. · 3 Biotech · 10

PDF

Terpinen-4-ol, An Active Constituent of Kewda Essential Oil, Mitigates Biofilm Forming Ability of Multidrug Resistant Staphylococcus aureus and Klebsiella pneumoniae

2022 · Priya Cheruvanachari, Subhaswaraj Pattnaik, et al. · Journal of Biologically Active Products from Nature · 8

9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells

2021 · A.K. Patel, R.K. Meher, et al. · SAR and QSAR in environmental research · 8

In silico design of novel tubulin binding 9-arylimino derivatives of noscapine, their chemical synthesis and cellular activity as potent anticancer agents against breast cancer

2021 · Rajesh Kumar Meher, Praveen Kumar Reddy Nagireddy, et al. · Journal of Biomolecular Structure and Dynamics · 8

Pyrazole-Infused Metal Complexes: Anticancer Activity, DNA Cleavage, and Biophysical Insights into DNA/BSA Interactions

2025 · Tankadhar Behera, Jyotiprabha Rout, et al. · ACS Applied Bio Materials · 7

Design, synthesis, characterization and biological evaluation of 2H-chromene based [1,2-c]pyrazolone derivatives as promising anticancer agents: In silico computational studies

2025 · Bhabani Shankar Panda, Barsha Samanta, et al. · Journal of Molecular Structure · 6

Elucidating the therapeutic efficacy of polyherbal formulation for the management of diabetes through endogenous pancreatic β-cell regeneration

2025 · Abhijit Sahu, Pravash Ranjan Mishra, et al. · Bioorganic Chemistry · 6

In‐Silico‐Inspired Design of 1,3‐Diynyl Congeners of Noscapine as Promising Tubulin‐Binding Anticancer Agent: Chemical Synthesis and Cellular Activity with Breast Cancer Cell Lines

2021 · Pratyush Pragyandipta, Rajesh K. Meher, et al. · ChemistrySelect · 6

Potent Therapeutic Efficacy of 9‐Bromo‐Noscapine Against Breast Cancer Cells Via Enhanced Bioavailability of the Noscapine‐Cyclodextrin Inclusion Complex

2025 · Namita Bhoi, Lilesh Kumar Pradhan, et al. · Drug Development Research · 5

Antiproliferative Noscapinoids Bearing an Amidothiadiazole Scaffold as Apoptosis Inducers: Design, Synthesis and Molecular Docking

2023 · Ravi Kumar Pedapati, Pratyush Pragyandipta, et al. · Chemistry & Biodiversity · 5

N-imidazopyridine derivatives of noscapine as potent tubulin-binding anticancer agents: chemical synthesis and cellular evaluation

2025 · Pooja Dash, Pratyush Pragyandipta, et al. · Journal of Computer-Aided Molecular Design · 4

In silico inspired design of urea noscapine congeners as anticancer agents: Chemical synthesis and experimental evaluation using breast cancer cells and a xenograft mouse model

2024 · Pratyush Pragyandipta, Eeshara Naik, et al. · European Journal of Medicinal Chemistry · 4

The mode of action of sorafenib in MDA-MB-231 breast carcinoma cells involves components of apoptotic, necroptotic and autophagy-dependent cell death pathways

2024 · Gudapureddy Radha, Pratyush Pragyandipta, et al. · Experimental Cell Research · 4

Structure Based Design of Tubulin Binding 9-Arylimino Noscapinoids: Chemical Synthesis and Experimental Validation Against Breast Cancer Cell Lines

2022 · Pratyush Pragyandipta, Rajesh Kumar Meher, et al. · Analytical Chemistry Letters · 3

Biochemical and in silico analysis of the binding mode of erastin with tubulin

2024 · Gudapureddy Radha, Pratyush Pragyandipta, et al. · Journal of Biomolecular Structure and Dynamics · 1

Phytochemical investigation and demonstration of free radical scavenging, antibacterial, antibiofilm, and antidiarrheal activities of Dalbergia volubilis

2026 · Monika Mishra, Dibya Ranjan Sahoo, et al. · Journal of Herbs Spices & Medicinal Plants

Antibacterial and Antibiofilm Efficacy of 2‐Phenyl Ethyl Methyl Ether Against Multidrug‐Resistant Klebsiella pneumoniae

2026 · Monika Mishra, Subhaswaraj Pattnaik, et al. · Chemistry & Biodiversity

Revolutionizing Cancer Treatment

2026 · Jyotirmayee, Pratyush Pragyandipta, et al. · CRC Press eBooks

Antiproliferative noscapinoids bearing isoxazoles: Design, synthesis, bioevaluation and molecular docking

2024 · Ravi Kumar Pedapati, Varshitha Shanigarapu, et al. · Tetrahedron

Works count: 29

Citation count: 155

H-index: 8

I10-index: 6